Stratec SE Cash Flow Conversion Efficiency
Stratec SE cash flow conversion efficiency. Based on the latest financial reports, Stratec SE (SBS) has a cash flow conversion efficiency ratio of 0.091x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€21.49 Million ≈ $25.13 Million USD) by net assets (€236.79 Million ≈ $276.84 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Stratec SE (2002–2025)
Cash flow conversion efficiency of Stratec SE from 2002 to 2025. This chart illustrates how Stratec SE's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Stratec SE for real-time trading data and today's change.
Stratec SE Cash Flow Conversion Ratio Explained
Stratec SE cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Stratec SE Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Stratec SE ranked by their cash flow conversion efficiency. Also see SBS stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Infotel SA
PA:INF
|
0.098x |
|
Xinjiang Tianshun Supply Chain Co Ltd
SHE:002800
|
-0.116x |
|
Lightbridge Corporation
F:N7ON
|
-0.022x |
|
Phihong Technology Co Ltd
TW:2457
|
0.012x |
|
Integrated Diagnostics Holdings PLC
LSE:IDHC
|
0.051x |
|
GENERALFINANCE SPA
F:VG30
|
-0.212x |
|
Letong Chemical Co Ltd
SHE:002319
|
0.058x |
|
Text S.A.
WAR:TXT
|
0.303x |
Annual Cash Flow Conversion Efficiency for Stratec SE (2002–2025)
The table below shows the annual cash flow conversion efficiency of Stratec SE from 2002 to 2025. Review how much free cash does Stratec SE generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €237.32 Million ≈ $277.45 Million |
€-433.00K ≈ $-506.22K |
-0.002x | -100.91% |
| 2024-12-31 | €242.53 Million ≈ $283.55 Million |
€48.71 Million ≈ $56.95 Million |
0.201x | +141.25% |
| 2023-12-31 | €233.33 Million ≈ $272.78 Million |
€19.43 Million ≈ $22.71 Million |
0.083x | +82.38% |
| 2022-12-31 | €225.18 Million ≈ $263.26 Million |
€10.28 Million ≈ $12.02 Million |
0.046x | -85.20% |
| 2021-12-31 | €205.76 Million ≈ $240.55 Million |
€63.47 Million ≈ $74.21 Million |
0.308x | +67.12% |
| 2020-12-31 | €172.54 Million ≈ $201.72 Million |
€31.85 Million ≈ $37.23 Million |
0.185x | +38.04% |
| 2019-12-31 | €159.01 Million ≈ $185.90 Million |
€21.26 Million ≈ $24.86 Million |
0.134x | +70.31% |
| 2018-12-31 | €152.20 Million ≈ $177.94 Million |
€11.95 Million ≈ $13.97 Million |
0.079x | -58.67% |
| 2017-12-31 | €157.84 Million ≈ $184.53 Million |
€29.98 Million ≈ $35.05 Million |
0.190x | +67.93% |
| 2016-12-31 | €143.72 Million ≈ $168.02 Million |
€16.26 Million ≈ $19.00 Million |
0.113x | -43.40% |
| 2015-12-31 | €130.28 Million ≈ $152.31 Million |
€26.03 Million ≈ $30.44 Million |
0.200x | -43.67% |
| 2014-12-31 | €112.05 Million ≈ $131.00 Million |
€39.75 Million ≈ $46.47 Million |
0.355x | +44.63% |
| 2013-12-31 | €97.18 Million ≈ $113.61 Million |
€23.84 Million ≈ $27.87 Million |
0.245x | +729.52% |
| 2012-12-31 | €91.98 Million ≈ $107.54 Million |
€2.72 Million ≈ $3.18 Million |
0.030x | -77.01% |
| 2011-12-31 | €83.23 Million ≈ $97.31 Million |
€10.71 Million ≈ $12.52 Million |
0.129x | +538.58% |
| 2010-12-31 | €71.88 Million ≈ $84.03 Million |
€1.45 Million ≈ $1.69 Million |
0.020x | -89.02% |
| 2009-12-31 | €59.29 Million ≈ $69.31 Million |
€10.88 Million ≈ $12.72 Million |
0.183x | +95.22% |
| 2008-12-31 | €49.90 Million ≈ $58.34 Million |
€4.69 Million ≈ $5.48 Million |
0.094x | -52.28% |
| 2007-12-31 | €48.58 Million ≈ $56.79 Million |
€9.57 Million ≈ $11.19 Million |
0.197x | -10.44% |
| 2006-12-31 | €40.13 Million ≈ $46.92 Million |
€8.83 Million ≈ $10.32 Million |
0.220x | +430.06% |
| 2005-12-31 | €31.52 Million ≈ $36.85 Million |
€1.31 Million ≈ $1.53 Million |
0.041x | -73.32% |
| 2004-12-31 | €15.47 Million ≈ $18.08 Million |
€2.41 Million ≈ $2.81 Million |
0.156x | +384.79% |
| 2003-12-31 | €12.87 Million ≈ $15.05 Million |
€413.00K ≈ $482.84K |
0.032x | -99.98% |
| 2002-12-31 | €11.17K ≈ $13.06K |
€1.73 Million ≈ $2.03 Million |
155.162x | -- |
About Stratec SE
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and instrumentation and softwar… Read more